These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 15447735

  • 1. Effect of itraconazole on the pharmacokinetics of inhaled lidocaine.
    Isohanni MH, Neuvonen PJ, Olkkola KT.
    Basic Clin Pharmacol Toxicol; 2004 Sep; 95(3):120-3. PubMed ID: 15447735
    [Abstract] [Full Text] [Related]

  • 2. Effect of erythromycin and itraconazole on the pharmacokinetics of oral lignocaine.
    Isohanni MH, Neuvonen PJ, Olkkola KT.
    Pharmacol Toxicol; 1999 Mar; 84(3):143-6. PubMed ID: 10193676
    [Abstract] [Full Text] [Related]

  • 3. Effect of erythromycin and itraconazole on the pharmacokinetics of intravenous lignocaine.
    Isohanni MH, Neuvonen PJ, Palkama VJ, Olkkola KT.
    Eur J Clin Pharmacol; 1998 Sep; 54(7):561-5. PubMed ID: 9832299
    [Abstract] [Full Text] [Related]

  • 4. Effect of fluvoxamine and erythromycin on the pharmacokinetics of oral lidocaine.
    Isohanni MH, Neuvonen PJ, Olkkola KT.
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):168-72. PubMed ID: 16918719
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of the CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function.
    Orlando R, Piccoli P, De Martin S, Padrini R, Palatini P.
    Br J Clin Pharmacol; 2003 Jan; 55(1):86-93. PubMed ID: 12534644
    [Abstract] [Full Text] [Related]

  • 8. The CYP3A4 inhibitor intraconazole does not affect the pharmacokinetics of a new calcium-sensitizing drug levosimendan.
    Antila S, Honkanen T, Lehtonen L, Neuvonen PJ.
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):446-9. PubMed ID: 9726699
    [Abstract] [Full Text] [Related]

  • 9. Fluconazole but not the CYP3A4 inhibitor, itraconazole, increases zafirlukast plasma concentrations.
    Karonen T, Laitila J, Niemi M, Neuvonen PJ, Backman JT.
    Eur J Clin Pharmacol; 2012 May; 68(5):681-8. PubMed ID: 22108774
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The CYP 3A4 inhibitor itraconazole has no effect on the pharmacokinetics of i.v. fentanyl.
    Palkama VJ, Neuvonen PJ, Olkkola KT.
    Br J Anaesth; 1998 Oct; 81(4):598-600. PubMed ID: 9924238
    [Abstract] [Full Text] [Related]

  • 13. Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid.
    Neuvonen PJ, Jalava KM.
    Clin Pharmacol Ther; 1996 Jul; 60(1):54-61. PubMed ID: 8689812
    [Abstract] [Full Text] [Related]

  • 14. Selegiline pharmacokinetics are unaffected by the CYP3A4 inhibitor itraconazole.
    Kivistö KT, Wang JS, Backman JT, Nyman L, Taavitsainen P, Anttila M, Neuvonen PJ.
    Eur J Clin Pharmacol; 2001 Apr; 57(1):37-42. PubMed ID: 11372588
    [Abstract] [Full Text] [Related]

  • 15. Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.
    Neuvonen PJ, Kantola T, Kivistö KT.
    Clin Pharmacol Ther; 1998 Mar; 63(3):332-41. PubMed ID: 9542477
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. No effect of itraconazole on the single oral dose pharmacokinetics and pharmacodynamics of estazolam.
    Otsuji Y, Okuyama N, Aoshima T, Fukasawa T, Kato K, Gerstenberg G, Miura M, Ohkubo T, Sugawara K, Otani K.
    Ther Drug Monit; 2002 Jun; 24(3):375-8. PubMed ID: 12021628
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Itraconazole, gemfibrozil and their combination markedly raise the plasma concentrations of loperamide.
    Niemi M, Tornio A, Pasanen MK, Fredrikson H, Neuvonen PJ, Backman JT.
    Eur J Clin Pharmacol; 2006 Jun; 62(6):463-72. PubMed ID: 16758263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.